Yu‐Jung Lin

1.3k total citations
48 papers, 1.0k citations indexed

About

Yu‐Jung Lin is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Yu‐Jung Lin has authored 48 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 10 papers in Cancer Research and 8 papers in Oncology. Recurrent topics in Yu‐Jung Lin's work include MicroRNA in disease regulation (5 papers), COVID-19 Clinical Research Studies (4 papers) and Cancer, Hypoxia, and Metabolism (4 papers). Yu‐Jung Lin is often cited by papers focused on MicroRNA in disease regulation (5 papers), COVID-19 Clinical Research Studies (4 papers) and Cancer, Hypoxia, and Metabolism (4 papers). Yu‐Jung Lin collaborates with scholars based in Taiwan, India and China. Yu‐Jung Lin's co-authors include Chia‐Hung Hsieh, Woei‐Cherng Shyu, Chung‐Pu Wu, Yen‐Ho Lai, San‐Yuan Chen, Chih‐Sheng Chiang, Hung‐Wei Cheng, Wei-Ling Chen, Chi-Chung Wang and Chih‐Yang Huang and has published in prestigious journals such as Nature Nanotechnology, The Journal of Clinical Endocrinology & Metabolism and Clinical Cancer Research.

In The Last Decade

Yu‐Jung Lin

46 papers receiving 995 citations

Peers

Yu‐Jung Lin
Lin Zhong China
Yinan Chen China
Amalia Luce Italy
Hongqin Zhang China
Jiajun Xu China
Yu‐Peng Liu Taiwan
Weiyue Zhang China
Rongrong Zhang China
Liqing Du China
Lin Zhong China
Yu‐Jung Lin
Citations per year, relative to Yu‐Jung Lin Yu‐Jung Lin (= 1×) peers Lin Zhong

Countries citing papers authored by Yu‐Jung Lin

Since Specialization
Citations

This map shows the geographic impact of Yu‐Jung Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu‐Jung Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu‐Jung Lin more than expected).

Fields of papers citing papers by Yu‐Jung Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yu‐Jung Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu‐Jung Lin. The network helps show where Yu‐Jung Lin may publish in the future.

Co-authorship network of co-authors of Yu‐Jung Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Yu‐Jung Lin. A scholar is included among the top collaborators of Yu‐Jung Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yu‐Jung Lin. Yu‐Jung Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lin, Shinn‐Zong, Kevin Chih‐Yang Huang, Yueh-Min Lin, et al.. (2025). The natural compound n-butylidenephthalide suppresses type II ovarian cancer cell growth by inducing ferroptosis. International Journal of Medical Sciences. 22(15). 3854–3867.
2.
Huang, Yu‐Nan, Wen‐Ling Liao, Jing‐Yang Huang, et al.. (2024). Long‐term safety and efficacy of glucagon‐like peptide‐1 receptor agonists in individuals with obesity and without type 2 diabetes: A global retrospective cohort study. Diabetes Obesity and Metabolism. 26(11). 5222–5232. 13 indexed citations
3.
4.
Lin, Tzu‐Ying, Chia‐Hua Kuo, Dennis Jine‐Yuan Hsieh, et al.. (2023). Ginkgolide A improves the pleiotropic function and reinforces the neuroprotective effects by mesenchymal stem cell-derived exosomes in 6-OHDA-induced cell model of Parkinson’s disease. Aging. 15(5). 1358–1370. 8 indexed citations
5.
Lee, Yuan‐Chieh, Yu‐Jung Lin, Rong‐Kung Tsai, et al.. (2023). Protective effects of Scoparia dulcis L. extract on high glucose-induced injury in human retinal pigment epithelial cells. Frontiers in Nutrition. 10. 1085248–1085248. 3 indexed citations
6.
Lin, Yu‐Jung, et al.. (2023). Development and evaluation of a novel chromium III-based compound for potential inhibition of emerging SARS-CoV-2 variants. Heliyon. 9(9). e20011–e20011. 1 indexed citations
7.
Lai, Yun‐Ju, Yu‐Jung Lin, Ching‐Chang Tsai, et al.. (2022). Seroprevalence and risk factors for cytomegalovirus infection among pregnant women in southern Taiwan, 2014–2015. Taiwanese Journal of Obstetrics and Gynecology. 61(2). 323–328. 5 indexed citations
8.
Wang, Huisheng, Marthandam Asokan Shibu, Ji‐Hung Wang, et al.. (2022). Clinical course of patients with severe SARS-CoV-2 infection co-treatment with Jin Si Herbal Tea in Eastern Taiwan: A retrospective cohort study. Journal of Herbal Medicine. 36. 100610–100610. 5 indexed citations
9.
Shibu, Marthandam Asokan, Yu‐Jung Lin, Cheng‐You Lu, et al.. (2022). Novel anti-aging herbal formulation Jing Si displays pleiotropic effects against aging associated disorders. Biomedicine & Pharmacotherapy. 146. 112427–112427. 16 indexed citations
10.
Kuo, Wei‐Wen, Yu‐Jung Lin, Chia‐Hua Kuo, et al.. (2022). Combined effect of traditional Chinese herbal-based formulations Jing Si herbal tea and Jing Si nasal drop inhibits adhesion and transmission of SARS-CoV2 in diabetic SKH-1 mice. Frontiers in Pharmacology. 13. 953438–953438. 5 indexed citations
11.
Hsu, Wei‐Chung, Yu‐Jung Lin, Ming‐Cheng Chen, et al.. (2021). Calmodulin/CaMKII‐γ mediates prosurvival capability in apicidin‐persistent hepatocellular carcinoma cells via ERK1/2/CREB/c‐fos signaling pathway. Journal of Cellular Biochemistry. 122(6). 612–625. 8 indexed citations
12.
Huang, Yen‐Chih, et al.. (2021). Gain of CXCR7 function with mesenchymal stem cell therapy ameliorates experimental arthritis via enhancing tissue regeneration and immunomodulation. Stem Cell Research & Therapy. 12(1). 314–314. 12 indexed citations
13.
Yu, Yang, et al.. (2019). Role of MicroRNA 146a in Regulating Regulatory T Cell Function to Ameliorate Acute Cardiac Rejection in Mice. Transplantation Proceedings. 51(3). 901–912. 7 indexed citations
14.
Chiang, Chih‐Sheng, Yu‐Jung Lin, Yen‐Ho Lai, et al.. (2018). Combination of fucoidan-based magnetic nanoparticles and immunomodulators enhances tumour-localized immunotherapy. Nature Nanotechnology. 13(8). 746–754. 235 indexed citations
15.
16.
Hsieh, Chia‐Hung, Yu‐Jung Lin, Chung‐Pu Wu, et al.. (2014). Livin Contributes to Tumor Hypoxia–Induced Resistance to Cytotoxic Therapies in Glioblastoma Multiforme. Clinical Cancer Research. 21(2). 460–470. 45 indexed citations
17.
Hsieh, Chia‐Hung, et al.. (2012). NADPH oxidase subunit 4 mediates cycling hypoxia-promoted radiation resistance in glioblastoma multiforme. Free Radical Biology and Medicine. 53(4). 649–658. 53 indexed citations
18.
Lin, Yu‐Jung, et al.. (2012). Tumor cycling hypoxia induces chemoresistance in glioblastoma multiforme by upregulating the expression and function of ABCB1. Neuro-Oncology. 14(10). 1227–1238. 83 indexed citations
19.
20.
Lin, Yu‐Jung, et al.. (1995). Codon 249 mutation of the p53 gene is a rare event in hepatocellular carcinomas from ethnic Chinese in Singapore. British Journal of Cancer. 72(1). 146–149. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lin Zhong Breakdown of academic impact, for papers by Yinan Chen Breakdown of academic impact, for papers by Amalia Luce Breakdown of academic impact, for papers by Hongqin Zhang Breakdown of academic impact, for papers by Jiajun Xu Breakdown of academic impact, for papers by Yu‐Peng Liu Breakdown of academic impact, for papers by Weiyue Zhang Breakdown of academic impact, for papers by Rongrong Zhang Breakdown of academic impact, for papers by Liqing Du
Rankless by CCL
2026